Cyclacel Pharma (CYCC) Misses Q2 EPS by 98c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Foreign exchange (losses)/gains: 51K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.98).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Worthington Industries (WOR) Misses Q4 EPS by 9c
- MSCI upgrades Bulgaria to Frontier, flags Indonesia and Turkey risks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
